跳至主要内容
临床试验/TCTR20200902002
TCTR20200902002已完成4 期

Comparative study of the effectiveness of Vaginal tablet : Metronidazole 750mg and Miconazole 200 mg and Oral Metronidazole for the treatment of Bacterial vaginosis : Randomized controlled trial

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 70 人开始时间: 2020年9月2日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
70

研究概览

简要总结

Vaginal tablets containing metronidazole 750mg plus miconazole nitrate 200mg shows non-significant superiority to 2g oral metronidazole in treating BV with comparable side effects.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Women aged 18-45 years old
  • Diagnosed Bacterial vaginosis with Amsel criteria
  • Can avoid sexual intercourse during 7-day course of treatment in vaginal suppository group
  • Not an immunocompromised host

排除标准

  • Had Bacterial vaginosis treatment in previous 3 months
  • Taking these certain medications in the previous 1 month e.g. anti-parasitics, antibiotics, immunosuppressants, steroids, vaginal medications, anticoagulants, disulfiram
  • Abnormal uterine bleeding
  • Being pregnant or lactating or having menstruation during the diagnosis and treatment
  • Frequently perform vaginal douching
  • Currently having sexual transmitted disease
  • Currently on the cervical intraepithelial neoplasia treatment or cervical cancer

研究者

相似试验